Acute retinal necrosis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Acute retinal necrosis}} {{CMG}} {{AE}} {{LRO}} ==Overview== ==Future or Investigational Therapies== ==References== {{Reflist|2}} {{WH}} {{WS}} Category:Opht...") |
m (Bot: Removing from Primary care) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute retinal necrosis}} | {{Acute retinal necrosis}} | ||
{{CMG}} {{AE}} {{LRO}} | {{CMG}}; {{AE}} {{LRO}} | ||
==Overview== | ==Overview== | ||
| Line 12: | Line 12: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
Latest revision as of 20:16, 29 July 2020
|
Acute retinal necrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute retinal necrosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Acute retinal necrosis future or investigational therapies |
|
FDA on Acute retinal necrosis future or investigational therapies |
|
CDC on Acute retinal necrosis future or investigational therapies |
|
Acute retinal necrosis future or investigational therapies in the news |
|
Blogs on Acute retinal necrosis future or investigational therapies |
|
Risk calculators and risk factors for Acute retinal necrosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.